PharmiWeb.com - Global Pharma News & Resources

Company Directory - Research & Development

Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.
LifeTein, the custom peptide synthesis service company, has developed proprietary PeptideSyn technology. This technology provides a platform for continuous peptide synthesis using microwave technology at a competitive price.
As a biotechnology company, Lifeasible is specialized in agricultural science, offering a wide variety of agro-related services and products for environmental and energy solutions.
MIMETAS strives to contribute to groundbreaking therapies with unique human disease biology, revealed by robust, screenable assays in the most versatile technology platform.
By integrating our proprietary COMPASS platform with our extensive technological and drug discovery capabilities, our team of scientific pioneers are working to accelerate the development of new precision medicines that change the course of disease.
MedAustron, the center for ion therapy and research is located in Wiener Neustadt in Lower Austria, about 50 kilometers south of Vienna. 180 employees coming from about 18 different countries are currently working for MedAustron. These include physicians, physicists, engineers, medical physicists, radiology technologists and administrative staff.